Data / Drug companies / Boswell Pharmacy Services LLC D/B/A BPS Wholesale
Boswell Pharmacy Services LLC D/B/A BPS Wholesale: 13 products in the FDA NDC directory, labeler code 83209
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Boswell Pharmacy Services LLC D/B/A BPS Wholesale (labeler code 83209) lists 13 products in the FDA National Drug Code Directory, covering 11 finished drugs by generic name. By type: 13 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 13, 2025.
The request: Watch Boswell Pharmacy Services LLC D/B/A BPS Wholesale (FDA labeler code 83209): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83209
- Products in commercial distribution
- 13
- Packages
- 50
- Finished drugs by generic name
- 11
- Prescription products
- 13
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- May 15, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 13 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Doxepin hydrochloride | 2 | 45 |
| Lovastatin | 2 | 22 |
| Omeprazole | 1 | 106 |
| Dapsone | 1 | 26 |
| Buspirone hydrochloride | 1 | 50 |
| Lithium carbonate | 1 | 24 |
| Naproxen | 1 | 58 |
| Amlodipine besylate | 1 | 49 |
| Gabapentin | 1 | 91 |
| Buspirone | 1 | 1 |
| Ibuprofen | 1 | 190 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 8 | 61.5% |
| Capsule | 4 | 30.8% |
| Capsule, delayed release | 1 | 7.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Buspirone Hydrochloride | 83209-303 | Tablet | Generic drugs (ANDA) | November 13, 2025 |
| Amlodipine Besylate | 83209-399 | Tablet | Generic drugs (ANDA) | October 21, 2025 |
| Lovastatin | 83209-143 | Tablet | Generic drugs (ANDA) | February 25, 2025 |
| Lovastatin | 83209-468 | Tablet | Generic drugs (ANDA) | February 24, 2025 |
| Doxepin hydrochloride | 83209-638 | Capsule | Generic drugs (ANDA) | September 4, 2024 |
| Doxepin Hydrochloride | 83209-424 | Capsule | Generic drugs (ANDA) | September 4, 2024 |
| Dapsone | 83209-566 | Tablet | Generic drugs (ANDA) | August 30, 2024 |
| Naproxen | 83209-190 | Tablet | Generic drugs (ANDA) | August 23, 2024 |
| Lithium Carbonate | 83209-220 | Capsule | Generic drugs (ANDA) | August 21, 2024 |
| Gabapentin | 83209-663 | Capsule | Generic drugs (ANDA) | July 26, 2024 |
| Omeprazole | 83209-150 | Capsule, delayed release | Generic drugs (ANDA) | June 12, 2024 |
| Ibuprofen | 83209-464 | Tablet | Generic drugs (ANDA) | June 3, 2024 |
| Buspirone Hydrochloride | 83209-554 | Tablet | Generic drugs (ANDA) | May 15, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.